Search clinical trials for: HS-10353 50mg oral capsules

Total 1053 results

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of HS-10353 in Adult Participants With Major Depressive Disorder

Major Depressive Disorder (MDD)
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Not yet recruiting

A Phase II Study of HS-10353 in Participants With Postpartum Depression

Postpartum Depression
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Completed

A Study of HS-10353 in Chinese Participants.

Major Depressive Disorder

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

A Study of HS-20094 in T2DM Participants

Type 2 Diabetes

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

A Multiple-Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of HS-10383

Cough

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of HS-10383 in Chinese Adult Subjects With Refractory or Unexplained Chronic Cough (RUCC)

Cough
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

First-in-Human Study to Investigate the Safety and Tolerability and Pharmacokinetics of HS-10383

Cough

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Unknown

Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Administration of HS-10356 in Healthy Volunteers

Healthy

China
Zhejiang Hisun Pharmaceutical Co. Ltd.

Unknown

Efficacy and Safety of HS-25 or in Combination With Atorvastatin in Chinese Adults With Primary Hypercholesterolemia (HS-25-C-01)

Primary Hypercholesterolemia
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer

Breast Cancer

China
Beijing Union Pharmaceutical Factory Ltd
R&G Pharma Studies Co.,Ltd.

Recruiting

Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD (BGFN-2022-02)

Generalized Anxiety Disorder

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

A Study of HS-10365 in Patients With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

Nonsmall Cell Lung Cancer

China
Reata, a wholly owned subsidiary of Biogen

Completed

Safety and PK/PD of RTA 1701 in Healthy Adults

Healthy

Australia
Galapagos NV

Completed

This is a Study to Evaluate the Effect of Aging of Multiple Doses of GLPG1205 in Healthy Subjects

Healthy | Elderly

Belgium
Guangzhou Yipinhong Pharmaceutical CO.,LTD

Completed

The Safety and Tolerability of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers

Chronic Hepatitis B

China
Georgetown University

Unknown

Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease (PD Nilotinib)

Parkinson Disease | Parkinsons Disease With Dementia

United States
Vanderbilt University Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Completed

Soluble Epoxide Hydrolase Inhibition and Insulin Resistance

Glucose Metabolism Disorders | Obesity | Diabetes Mellitus | Endocrine System Diseases | PreDiabetes

United States
Hansoh BioMedical R&D Company

Recruiting

A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis

Psoriasis

China
Chung Shan Medical University
Golden Biotechnology Corporation

Terminated

A Phase II, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patients With Atopic Dermatitis

Atopic Dermatitis

Taiwan
TaiGen Biotechnology Co., Ltd.

Completed

A Study Evaluating the Effect of a Single-dose Oral Administration of Nemonoxacin Capsule on QTc Intervals and Heart Rhythms of Healthy Subjects and the Influence of Food Intake on QTc Intervals and Pharmacokinetic Characteristics

Healthy Volunteers
Massachusetts General Hospital
Center for Microbiome Informatics and Therapeutics

Active, not recruiting

Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy

Hepatic Encephalopathy

United States
Northwestern University
University of Iowa; University of Rochester; Michael J. Fox Foundation for Parkinson...

Completed

Nilotinib in Parkinson's Disease (NILO-PD)

Parkinson Disease

United States
Medibiofarma S.L.

Completed

Study to Assess the Safety and Tolerability of MBF-118 in Healthy Volunteers

Cancer

Spain
Psychiatric Hospital of the University of Basel

Terminated

Fecal Microbiota Transplantation in Depression

Major Depressive Disorder

Switzerland
Cambridge University Hospitals NHS Foundation Trust
University of Cambridge

Active, not recruiting

Investigating the Lowest Threshold of Vascular Benefits From LDL Cholesterol Lowering in Patients With Stable CV Disease (INTENSITY-HIGH)

Cardiovascular Diseases | Atherosclerosis

United Kingdom
DS Biopharma

Terminated

Efficacy and Safety of Orally Administered DS107 in Adult Patients With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

United States, Austria, Germany, Latvia, Poland
Hansoh BioMedical R&D Company

Not yet recruiting

Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis

Psoriatic Arthritis
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer

Breast Cancer

China
Beijing Union Pharmaceutical Factory Ltd
R&G Pharma Studies Co.,Ltd.

Recruiting

Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD (BGFN-2022-01)

Generalized Anxiety Disorder

China
Palobiofarma SL
Clínica Universidad de Navarra

Completed

Study to Assess the Safety and Tolerability of PBF-1650 in Healthy Volunteers. (ADENOIMMUNE)

Psoriasis

Spain
Prexton Therapeutics

Withdrawn

Study to Evaluate the Efficacy, Safety, and Tolerability of PXT002331 (Foliglurax) in Reducing Levodopa-Induced Dyskinesia and Wearing OFF in Subjects With Parkinson's Disease Experiencing Motor Complications of Levodopa Therapy (ATTUNED) (ATTUNED)

Parkinson Disease
Yale University

Completed

Cranberry for UTI Prevention in Residents of Long Term Care Facilities (PACS)

Urinary Tract Infection

United States
Al-Kindy College of Medicine

Completed

The Effect of Cinnamon on Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome; a Pilot Study

Chronic Prostatitis | Chronic Pelvic Pain Syndrome

Iraq
Purdue Pharma, Canada

Completed

PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD

ADHD

United States
Purdue Pharma, Canada

Completed

PRC-063 Adult Laboratory Classroom Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

ADHD

United States
Klinikum Nürnberg

Recruiting

A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease. (DapaBalci-Leap)

Chronic Renal Failure | Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis

Germany, France
Burnasyan Federal Medical Biophysical Center

Completed

Clinical Study of Medicinal Product Cardionat® Using in Health Athlete Volunteers

Angina Pectoris | Stroke, Not Specified as Hemorrhage or Infarction

Russian Federation
University of Calgary
Cumming school of medicine; The W. Garfield Westin Foundation

Recruiting

The Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Major Depressive Disorder

Depression | Treatment Resistant Depression

Canada
Garvan Institute of Medical Research

Completed

Alkaline Diet for Insulin Sensitivity (ADIS)

Type 2 Diabetes Mellitus | Dysglycemia

Australia
Guangzhou Yipinhong Pharmaceutical CO.,LTD

Unknown

The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B

Chronic Hepatitis B

China
Biota Pharma Europe Limited

Completed

Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study

Respiratory Syncytial Virus (RSV) Infection

United Kingdom
Montefiore Medical Center

Completed

Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome

Irritable Bowel Syndrome

United States
Brigham and Women's Hospital

Completed

DAW1033D in Obstructive Sleep Apnea (OSAstimD)

Obstructive Sleep Apnea (OSA)

United States
Aelis Farma
National Institute on Drug Abuse (NIDA)

Completed

Multiple Ascending Dose to Study the Safety, Tolerability, PK and PD Effects of AEF0117

Healthy Volunteers

United States
Brigham and Women's Hospital

Enrolling by invitation

DAW2020 on OSA Endotypic Traits (SedOSA)

Obstructive Sleep Apnea (OSA)

United States
EicOsis Human Health Inc.
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Safety, Tolerability, and Pharmacokinetics of Oral EC5026 in Healthy Subjects

Healthy Adults

United States
Brigham and Women's Hospital

Completed

DAW1033B2 in Obstructive Sleep Apnea (OsaStimB2)

Obstructive Sleep Apnea (OSA)

United States
Michael J. Wesley, PhD
National Institute on Drug Abuse (NIDA)

Completed

Neural Mechanisms of Cannabinoid-impaired Decision-Making in Emerging Adults

Substance-Related Disorders | Behavior Problem | Neurosciences

United States
Onconic Therapeutics Inc.

Completed

Clinical Trial to Evaluate the Safety and Pharmacokinetics of JP-1366 in Healthy Adult Volunteers

Healthy

Korea, Republic of
BioCryst Pharmaceuticals

Completed

Study to Evaluate the Efficacy and Safety of BCX7353 as an Oral Treatment for the Prevention of HAE Attacks in Japan (APeX-J)

Hereditary Angioedema, HAE

Japan

Search clinical trials for: HS-10353 50mg oral capsules

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations